ATRC Financial Facts
Other: -32KResearch and development expenses: 8.27M
See Full Income Statement
Accrued liabilities: 15.01M
Accumulated other comprehensive income: -449K
See Full Balance Sheet
AtriCure, Inc. (ATRC) Earnings
|
Expand Research on ATRC
| Next EPS Date | 11/4/26 | EPS Growth Rate | -300.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +562.7% | Revenue Growth Rate | +12.6% |
| Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/26  |
Q326 | N/A | -$0.04 | N/A | N/A | $151.18M | = | N/A | N/A | ||
| 7/23/26 | Q226 | $0.18 | -$0.01 | +$0.19 | $153.6M | $151.84M | = |  | | Details | |
| 5/5/26 | Q126 | $0.00 | -$0.06 | +$0.06 | $141.2M | $139.54M | = | | | Details | |
| 2/17/26 | Q425 | $0.06 | -$0.10 | +$0.16 | $140.5M | $139.55M | = | | | Details | |
| 10/29/25 | Q325 | -$0.01 | -$0.11 | +$0.10 | $134.3M | $131.25M | = | | | Details | |
| 7/29/25 | Q225 | -$0.13 | -$0.17 | +$0.04 | $136.1M | $130.17M | = | | | Details | |
| 4/29/25 | Q125 | -$0.14 | -$0.22 | +$0.08 | $123.6M | $123.08M | = | | | Details | |
| 2/12/25 | Q424 | -$0.33 | -$0.20 | -$0.13 | $124.28M | $120.37M | = | | | Details |
